Article Details
Retrieved on: 2021-01-26 01:14:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The industry benchmark, iShares NASDAQ Biotechnology ETF (IBB), is up ~11% so far in January -- far better than the S&P 500's 3% return. Covering ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here